Serina Therapeutics, Inc.SERNYSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+106.5%
5Y CAGR+15.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+106.5%/yr
vs -30.9%/yr prior
5Y CAGR
+15.2%/yr
Recent acceleration
Acceleration
+137.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.34M | +20.3% |
| 2024 | $9.43M | +142.2% |
| 2023 | $3.89M | +202.1% |
| 2022 | $1.29M | -0.7% |
| 2021 | $1.30M | -76.8% |
| 2020 | $5.60M | -29.5% |
| 2019 | $7.94M | +40.6% |
| 2018 | $5.65M | +46.0% |
| 2017 | $3.87M | -31.2% |
| 2016 | $5.62M | - |